Literature DB >> 9633692

Familial aggregation in frontotemporal dementia.

M Stevens1, C M van Duijn, W Kamphorst, P de Knijff, P Heutink, W A van Gool, P Scheltens, R Ravid, B A Oostra, M F Niermeijer, J C van Swieten.   

Abstract

OBJECTIVE AND
BACKGROUND: Frontotemporal dementia (FTD) is a common, non-Alzheimer's dementia. Its familial occurrence has been reported, but the frequency of positive family history is unknown.
METHODS: We carried out a nationwide genetic-epidemiologic study of FTD in the Dutch population of 15 million people. The family history of dementia was analyzed in 74 FTD patients and 561 age- and gender-matched control subjects.
RESULTS: We found one or more first-degree relatives with dementia before age 80 in 38% (28 of 74) of FTD patients, but only in 15% (84 of 561) of control subjects. Ten percent of FTD patients had two or more first-degree relatives with dementia compared with 0.9% of the control subjects. Seven percent of FTD patients showed the ApoE4E4 genotype versus 2.3% of the control subjects. The first-degree relatives of FTD had a risk of 22% for dementia before age 80 compared with 11% in relatives of control subjects. The age of onset of dementia in affected first-degree relatives of FTD patients (60.9+/-10.6 years) was significantly lower than among affected relatives of control subjects (72.3+/-8.5 years). The first-degree relatives of FTD patients were 3.5 times (95% CI, 2.4 to 5.2) more at risk for developing dementia before age 80 than relatives of control subjects. The hazard ratio in the subgroup with unknown linkage to chromosome 17 was 2.4 (95% CI, 1.5 to 3.7).
CONCLUSION: This study documents the importance of genetic factors in a proportion of FTD patients with the age at onset of dementia in first-degree relatives being 11 years earlier than in the general population.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9633692     DOI: 10.1212/wnl.50.6.1541

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  38 in total

1.  Frontotemporal dementia and neuropsychology: the value of missing values.

Authors:  H M Smeding; I de Koning
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-06       Impact factor: 10.154

2.  Corticobasal ganglionic degeneration and/or frontotemporal dementia? A report of two overlap cases and review of literature.

Authors:  P S Mathuranath; J H Xuereb; T Bak; J R Hodges
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-03       Impact factor: 10.154

Review 3.  Frontotemporal dementia.

Authors:  Erik D Roberson
Journal:  Curr Neurol Neurosci Rep       Date:  2006-11       Impact factor: 5.081

4.  Novel progranulin mutation detected in 2 patients with FTLD.

Authors:  Lena Skoglund; Toshifumi Matsui; Stefanie H Freeman; Anders Wallin; Elin S Blom; Matthew P Frosch; John H Growdon; Bradley T Hyman; Lars Lannfelt; Martin Ingelsson; Anna Glaser
Journal:  Alzheimer Dis Assoc Disord       Date:  2011 Apr-Jun       Impact factor: 2.703

5.  Frequency of progranulin mutations in a German cohort of 79 frontotemporal dementia patients.

Authors:  Johannes Carolus Magnus Schlachetzki; Klaus Schmidtke; Jan Beckervordersandforth; Wiktor Borozdin; Christian Wilhelm; Michael Hüll; Jürgen Kohlhase
Journal:  J Neurol       Date:  2009-07-19       Impact factor: 4.849

Review 6.  Pathology in primary progressive aphasia syndromes.

Authors:  Jennifer M Harris; Matthew Jones
Journal:  Curr Neurol Neurosci Rep       Date:  2014-08       Impact factor: 5.081

7.  Frontotemporal dementia in a large Swedish family is caused by a progranulin null mutation.

Authors:  Lena Skoglund; RoseMarie Brundin; Tommie Olofsson; Hannu Kalimo; Sofie Ingvast; Elin S Blom; Vilmantas Giedraitis; Martin Ingelsson; Lars Lannfelt; Hans Basun; Anna Glaser
Journal:  Neurogenetics       Date:  2008-10-15       Impact factor: 2.660

8.  High prevalence of mutations in the microtubule-associated protein tau in a population study of frontotemporal dementia in the Netherlands.

Authors:  P Rizzu; J C Van Swieten; M Joosse; M Hasegawa; M Stevens; A Tibben; M F Niermeijer; M Hillebrand; R Ravid; B A Oostra; M Goedert; C M van Duijn; P Heutink
Journal:  Am J Hum Genet       Date:  1999-02       Impact factor: 11.025

9.  No evidence of PGRN or MAPT gene dosage alterations in a collection of patients with frontotemporal lobar degeneration.

Authors:  Lena Skoglund; Sofie Ingvast; Toshifumi Matsui; Stefanie H Freeman; Matthew P Frosch; Rosemarie Brundin; Vilmantas Giedraitis; John H Growdon; Bradley T Hyman; Lars Lannfelt; Martin Ingelsson; Anna Glaser
Journal:  Dement Geriatr Cogn Disord       Date:  2009-11-23       Impact factor: 2.959

Review 10.  The molecular genetics and neuropathology of frontotemporal lobar degeneration: recent developments.

Authors:  Ian R A Mackenzie; Rosa Rademakers
Journal:  Neurogenetics       Date:  2007-09-06       Impact factor: 2.660

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.